Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,654 | 590 | 75.7% |
| Travel and Lodging | $3,035 | 12 | 21.6% |
| Consulting Fee | $196.33 | 1 | 1.4% |
| Education | $196.13 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertiflex, Inc. | $1,960 | 18 | $0 (2019) |
| Spinal Simplicity, LLC | $1,891 | 15 | $0 (2024) |
| Relievant Medsystems, Inc. | $1,084 | 13 | $0 (2023) |
| Boston Scientific Corporation | $1,049 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,036 | 83 | $0 (2024) |
| PFIZER INC. | $578.61 | 61 | $0 (2020) |
| ABBVIE INC. | $442.48 | 24 | $0 (2024) |
| Egalet US Inc | $408.73 | 63 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $406.49 | 28 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $311.88 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,723 | 50 | Spinal Simplicity, LLC ($759.70) |
| 2023 | $1,758 | 47 | Relievant Medsystems, Inc. ($1,084) |
| 2022 | $1,979 | 59 | Spinal Simplicity, LLC ($890.27) |
| 2021 | $1,131 | 52 | Nalu Medical, Inc. ($194.65) |
| 2020 | $1,117 | 56 | Boston Scientific Corporation ($478.87) |
| 2019 | $3,401 | 109 | Vertiflex, Inc. ($1,960) |
| 2018 | $1,527 | 119 | PFIZER INC. ($240.21) |
| 2017 | $1,447 | 115 | Jazz Pharmaceuticals Inc. ($269.08) |
All Payment Transactions
607 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Opioid Analgesic | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Opioid Analgesic | ||||||
| 11/11/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: SPINAL HARDWARE | ||||||
| 10/23/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Opioid Analgesic | ||||||
| 09/30/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/27/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Opioid Analgesic | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Gastroenterology | ||||||
| 08/02/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $42.74 | General |
| Category: Not Applicable | ||||||
| 07/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/17/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 07/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Gastroenterology | ||||||
| 06/14/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $11.37 | General |
| Category: Pain management | ||||||
| 06/03/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $44.44 | General |
| Category: SPINAL HARDWARE | ||||||
| 05/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Gastroenterology | ||||||
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Gastroenterology | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,478 | 7,304 | $2.0M | $176,731 |
| 2022 | 28 | 1,660 | 7,872 | $1.4M | $258,831 |
| 2021 | 27 | 1,680 | 4,944 | $1.2M | $237,987 |
| 2020 | 24 | 1,689 | 9,155 | $1.3M | $230,031 |
All Medicare Procedures & Services
167 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 59 | 79 | $224,400 | $17,735 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 263 | $216,975 | $16,979 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 154 | $161,700 | $14,068 | 8.7% |
| 62264 | Removal of spinal canal scar tissue, multiple sessions in 1 day | Office | 2023 | 28 | 36 | $134,352 | $12,294 | 9.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 96 | 96 | $108,000 | $10,772 | 10.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 74 | 89 | $78,690 | $8,298 | 10.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 16 | 18 | $81,006 | $8,198 | 10.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 22 | 36 | $87,345 | $6,329 | 7.2% |
| 62264 | Removal of spinal canal scar tissue, multiple sessions in 1 day | Facility | 2023 | 29 | 36 | $43,488 | $5,773 | 13.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 13 | 16 | $54,240 | $5,731 | 10.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 26 | 27 | $53,439 | $5,650 | 10.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 37 | 57 | $45,514 | $5,023 | 11.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 13 | 25 | $63,336 | $4,775 | 7.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 15 | 17 | $27,720 | $4,201 | 15.2% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Office | 2023 | 12 | 18 | $52,155 | $4,069 | 7.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $38,700 | $3,700 | 9.6% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 12 | 15 | $15,750 | $3,278 | 20.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 31 | 37 | $94,350 | $3,198 | 3.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 20 | 33 | $48,636 | $3,082 | 6.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 20 | 21 | $39,044 | $2,986 | 7.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 35 | 54 | $38,828 | $2,789 | 7.2% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 18 | 29 | $18,375 | $2,755 | 15.0% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 20 | 31 | $40,920 | $2,521 | 6.2% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 13 | 25 | $41,580 | $2,477 | 6.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 24 | 31 | $36,465 | $2,045 | 5.6% |
About Dr. Michael Boedefeld, MD
Dr. Michael Boedefeld, MD is a Anesthesiology healthcare provider based in Fenton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043299548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Boedefeld, MD has received a total of $14,082 in payments from pharmaceutical and medical device companies, with $1,723 received in 2024. These payments were reported across 607 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($10,654).
As a Medicare-enrolled provider, Boedefeld has provided services to 6,507 Medicare beneficiaries, totaling 29,275 services with total Medicare billing of $903,580. Data is available for 4 years (2020–2023), covering 167 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Fenton, MO
- Active Since 01/12/2006
- Last Updated 10/20/2020
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1043299548
Products in Payments
- Superion ISS (Device) $1,960
- HA MINUTEMAN G3-R (Device) $1,891
- Intracept (Device) $1,261
- RELISTOR (Drug) $960.98
- LYRICA (Drug) $529.29
- SUPERION (Device) $448.43
- Horizant (Drug) $311.88
- Prialt (Drug) $304.25
- Nalu Neurostimulation System (Device) $282.92
- WaveWriter Alpha Prime 16 (Device) $220.86
- Prometra II (Device) $209.30
- PRIALT (Drug) $190.42
- Morphabond ER (Drug) $181.95
- Omnia (Device) $176.08
- Belbuca (Drug) $173.35
- UBRELVY (Drug) $172.57
- OXAYDO (Drug) $171.93
- BOTOX (Biological) $164.56
- AIMOVIG (Biological) $161.59
- ARYMO ER (Drug) $156.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.